CBS 2019
CBSMD教育中心
中 文

急性冠脉综合征

Abstract

Recommended Article

BMI, Infarct Size, and Clinical Outcomes Following Primary PCI Patient-Level Analysis From 6 Randomized Trials Evaluation and Management of Nonculprit Lesions in STEMI Decreased inspired oxygen stimulates de novo formation of coronary collaterals in adult heart Early versus delayed invasive intervention in acute coronary syndromes Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI New technologies for intensive prevention programs after myocardial infarction: rationale and design of the NET-IPP trial Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI Heart Regeneration by Endogenous Stem Cells and Cardiomyocyte Proliferation: Controversy, Fallacy, and Progress

Original ResearchVolume 13, Issue 10, May 2020

JOURNAL:JACC: Cardiovascular Interventions Article Link

Evaluation and Management of Nonculprit Lesions in STEMI

T Thim, NW van der Hoeven, C Musto et al. Keywords: CFR; FFR; iFR; nonculprit coronary lesions; STEMI

ABSTRACT

Nonculprit lesions are frequently observed in patients with ST-segment elevation myocardial infarction. Results from recent randomized clinical trials suggest that complete revascularization after ST-segment elevation myocardial infarction improves outcomes. In this state-of-the-art paper, the authors review these trials and consider how best to determine which nonculprit lesions require revascularization and when this should be performed.